BASE DOCUMENTAL DE LA ACTUALIZACIÓN MÉDICO-CONTINUADA EN PREVENCIÓN DEL CÁNCER Y MEDICINA DE PRECISIÓN

Cancer Prevention and Precision Medicine

Search Result Summary

CDC Resources

• CDC Web Information (1 )
• CDC-Authored Genomics Publications (70 )

Discoveries and Insights

• Hot Topics (358)
• Genomics & Health Impact Scan (52)
• AMD Weekly Clips(8)
• Relevant Resources (2)

Epidemiology

• Human Genome Epidemiology (23706)
• AMD Clips (0)
• Relevant Resources (1)

Translational Research

• Genomics & Health Impact Scan (628)
• AMD Weekly Clips (0)

Evidence Synthesis

• Guidelines (9)
• Evidence Classification (69)
• Genomics & Health Impact Scan (159)
• Relevant Resources (1)

Practice and Implementation

• Implementation (190)
• Genomics & Health Impact Scan (29)
• Relevant Resources (5)

What's New

Last Updated: Jan 14, 2016

• Reach of the Montana Cancer Control Program to Women with Disabilities.
  Disease: Breast Cancer|Ovarian Cancer; Type: Data|Program; State: Montana (From Implementation Database)
• Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet
  Ngeow J, et al. Genomic Medicine 1, (2016)Jan 13 (From Genomics & Health Impact Scan Database)
• Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing.
  Liu Suqin et al. Human genomics 2015 92 (From Genomics & Health Impact Scan Database)
• Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
  Kensler Thomas W et al. Cancer prevention research (Philadelphia, Pa.) 2016 Jan 9(1) 2-10 (FromGenomics & Health Impact Scan Database)
• The role of genomics in the management of advanced bladder cancer.
  Guancial Elizabeth A et al. Current treatment options in oncology 2015 Jan (1) 319 (From Discoveries and Insights Database)
• Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer.
  Alva Ajjai et al. The Journal of urology 2015 Sep (3) 790-8 (From Discoveries and Insights Database)
• From the Frontiers of Health and Medicine: Experts urge Biden to expand access to patient genetics in cancer ‘moonshot’ 
  STatnews, January 13, 2016 (From Discoveries and Insights Database)
• Transforming Cancer Prevention through Precision Medicine and Immune-oncology
  TW Kensler et al, Cancer Prevention Research, January 8, 2016 (From Discoveries and Insights Database)
• Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
  Pereira Elena et al. PloS one 2015 10(12) e0145754 (From Genomics & Health Impact Scan Database)
• Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
  Lebofsky Ronald et al. Molecular oncology 2015 Apr 9(4) 783-90 (From Genomics & Health Impact Scan Database)
• Identifying Red Flags and Patterns that Increase Risk
  Disease: Multiple Diseases; Type: Education; State: Multiple States (From Implementation Database)
• Interpreting Genetic Testing Results
  Disease: Multiple Diseases; Type: Education; State: Multiple States (From Implementation Database)
• Pre-Test Decisions & Counseling
  Disease: Multiple Diseases; Type: Education; State: Multiple States (From Implementation Database)
• Categorizing Cancer Risk (average, familial, hereditary)
  Disease: Multiple Diseases; Type: Education; State: Multiple States (From Implementation Database)
• Collecting Family History 
  Disease: Multiple Diseases; Type: Education; State: Multiple States (From Implementation Database)
• Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
  Disease: Cancer; Type: Data; State: Delaware (From Implementation Database)
• Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment.
  Disease: Multiple Diseases; Type: Data|Tools; State: Illinois (From Implementation Database)
• Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening.
  Disease: Breast Cancer|Ovarian Cancer; Type: Data|Program; State: Michigan (From Implementation Database)
• A study of the impact of the 21-gene breast cancer assay on the use of adjuvant chemotherapy in women with breast cancer in a Mexican public hospital.
  Bargallo Juan Enrique et al. Journal of surgical oncology 2015 Feb 111(2) 203-7 (From Genomics & Health Impact Scan Database)
• Genomic Classification of Cutaneous Melanoma.
  Cell 2015 Jun (7) 1681-96 (From Discoveries and Insights Database)